|
CN106588881A
|
|
Method for preparing Vandetanib compound used for Vandetanib composition dry suspension serving as anti-tumor drug
|
|
CN106588882A
|
|
Vandetanib compound for Vandetanib composition dry suspension as antitumor drug
|
|
CN106588883A
|
|
Method for preparing vandetanib compound applied in antitumor drug vandetanib composition capsule
|
|
CN106749459A
|
|
A kind of nelarabine compound for antineoplastic nelarabine composition
|
|
CN106727332A
|
|
A kind of antineoplastic nelarabine powder-injection composition
|
|
CN106588879A
|
|
Method for preparing antitumor drug vandetanib compound
|
|
CN106581036A
|
|
Antitumor drug nelarabine powder injection
|
|
CN106588880A
|
|
Antitumor drug vandetanib compound
|
|
CN106581002A
|
|
Antitumor drug vandetanib composition particles
|
|
CN106589028A
|
|
Method for preparing antitumor drug nelarabine compound
|
|
CN106397458A
|
|
Ceftazidime crystal compound as drug for treating infection during surgical operation
|
|
CN106397457A
|
|
Drug ceftibuten crystal compound for treating surgical operation infection
|
